NCT05216744View on ClinicalTrials.gov

Comparison of Efficacy of Two Combination Regimens for the Neisseria Gonorrhoeae and Chlamydia Coinfection

PHASE2CompletedINTERVENTIONAL
Enrollment

125

Participants

Timeline

Start Date

July 15, 2021

Primary Completion Date

February 15, 2022

Study Completion Date

February 20, 2022

Conditions
Neisseria Gonorrhoeae InfectionChlamydia Trachomatis Infection
Interventions
DRUG

Ceftriaxone 1000mg + doxycycline 100 mg

Study comparing the effectiveness of two combination regimens in the treatment of gonorrhea and chlamydia, including regimen A (100mg doxycycline orally twice a day for 7 days + 1 dose of 1000mg ceftriaxone intravenously) and regimen B (100mg doxycycline). orally for 7 days + 1 oral dose of 800mg cefixime)

DRUG

Cefixime 800mg + doxycycline 100 mg

Study comparing the effectiveness of two combination regimens in the treatment of gonorrhea and chlamydia, including regimen A (100mg doxycycline orally twice a day for 7 days + 1 dose of 1000mg ceftriaxone intravenously) and regimen B (100mg doxycycline). orally for 7 days + 1 oral dose of 800mg cefixime)

Trial Locations (1)

18000

Haiphong International Hospital, Haiphong

All Listed Sponsors
lead

Haiphong University of Medicine and Pharmacy

OTHER